Status and Advances of RGD Molecular Imaging in Lung Cancer

Lung cancer has been one of the most common and the highest mortality rates malignant tumors at home and abroad. Sustained angiogenesis was not only the characteristic of malignant tumors, but also the foundation of tumor proliferation, invasion, recurrence and metastasis, it was also one of the hot...

Full description

Bibliographic Details
Main Authors: Ning YUE, Shuanghu YUAN, Guoren YANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-12-01
Series:Chinese Journal of Lung Cancer
Subjects:
RGD
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.06
id doaj-04721c9d843b4a4193b621bf151b5d61
record_format Article
spelling doaj-04721c9d843b4a4193b621bf151b5d612020-11-24T21:15:15ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34192014-12-01171285585910.3779/j.issn.1009-3419.2014.12.06Status and Advances of RGD Molecular Imaging in Lung CancerNing YUE0Shuanghu YUAN1Guoren YANG2Department of Nuclear Medicine, Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan 250117, ChinaDepartment of Nuclear Medicine, Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan 250117, ChinaDepartment of Nuclear Medicine, Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Jinan 250117, ChinaLung cancer has been one of the most common and the highest mortality rates malignant tumors at home and abroad. Sustained angiogenesis was not only the characteristic of malignant tumors, but also the foundation of tumor proliferation, invasion, recurrence and metastasis, it was also one of the hot spots of treatments in lung cancer biology currently. Integrins played an important part in tumor angiogenesis. Arg-Gly-Asp (RGD) peptides could combine with integrins specifically, and the application of radionuclide-labeled RGD molecular probes enabled imaging of tumor blood vessels to reflect its changes. The lung cancer imaging of RGD peptides at home and abroad in recent years was reviewed in this article.http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.06RGDIntegrinLung neoplasmsMolecular imagingAngiogenesis
collection DOAJ
language zho
format Article
sources DOAJ
author Ning YUE
Shuanghu YUAN
Guoren YANG
spellingShingle Ning YUE
Shuanghu YUAN
Guoren YANG
Status and Advances of RGD Molecular Imaging in Lung Cancer
Chinese Journal of Lung Cancer
RGD
Integrin
Lung neoplasms
Molecular imaging
Angiogenesis
author_facet Ning YUE
Shuanghu YUAN
Guoren YANG
author_sort Ning YUE
title Status and Advances of RGD Molecular Imaging in Lung Cancer
title_short Status and Advances of RGD Molecular Imaging in Lung Cancer
title_full Status and Advances of RGD Molecular Imaging in Lung Cancer
title_fullStr Status and Advances of RGD Molecular Imaging in Lung Cancer
title_full_unstemmed Status and Advances of RGD Molecular Imaging in Lung Cancer
title_sort status and advances of rgd molecular imaging in lung cancer
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
series Chinese Journal of Lung Cancer
issn 1009-3419
publishDate 2014-12-01
description Lung cancer has been one of the most common and the highest mortality rates malignant tumors at home and abroad. Sustained angiogenesis was not only the characteristic of malignant tumors, but also the foundation of tumor proliferation, invasion, recurrence and metastasis, it was also one of the hot spots of treatments in lung cancer biology currently. Integrins played an important part in tumor angiogenesis. Arg-Gly-Asp (RGD) peptides could combine with integrins specifically, and the application of radionuclide-labeled RGD molecular probes enabled imaging of tumor blood vessels to reflect its changes. The lung cancer imaging of RGD peptides at home and abroad in recent years was reviewed in this article.
topic RGD
Integrin
Lung neoplasms
Molecular imaging
Angiogenesis
url http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.06
work_keys_str_mv AT ningyue statusandadvancesofrgdmolecularimaginginlungcancer
AT shuanghuyuan statusandadvancesofrgdmolecularimaginginlungcancer
AT guorenyang statusandadvancesofrgdmolecularimaginginlungcancer
_version_ 1716745787408384000